Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists

Details for Australian Patent Application No. 2008240773 (hide)

Owner Glaxo Group Limited

Inventors Giblin, Gerard Martin Paul; Norton, David; Myatt, James; Rivers, Dean Andrew; Ahmed, Mahmood

Agent Davies Collison Cave

Pub. Number AU-A-2008240773

PCT Pub. Number WO2008/128951

Priority 0707617.7 19.04.07 GB; 0805993.3 02.04.08 GB

Filing date 17 April 2008

Wipo publication date 30 October 2008

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/128951 Priority application(s): WO2008/128951

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240779-Electrodes with mechanically roughened surface for electrochemical applications

2008240764-Tricyclic nitrogen containing compounds as antibacterial agents